High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus

Ali A. Al-Jabri, Amal K. Al-Gahdani, Ibtisam Al-Shuaili

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

This study was conducted to investigate the frequency and significance of some antinuclear autoantibodies in Omani patients with systemic lupus erythematosus (SLE). Anti-nuclear antibodies (ANA), anti-double stranded-DNA (anti-dsDNA), and anti-Smith (anti-Sm) autoantibodies were investigated in 60 Omani patients clinically diagnosed with SLE according to the American College of Rheumatology Criteria. The SLE group included 57 females and 3 males with an average age of 26 years. In addition, a group of 60 healthy Omanis (26 females and 34 males; average age 25 years) was used as a control. ANA patterns and autoantibody profile were assayed by indirect immunofluorescence assay using Hep-2 cells and liver/kidney/stomach tissue, respectively. Anti-dsDNA were examined by enzyme-linked immunosorbent assays; anti-Sm antibodies were measured by immunoblotting technique. Out of the 60 SLE patients, 59/60 (98.3%) were seropositive for ANA. Anti-dsDNA and anti-Sm each was detected in 50/60 (83.3%) of the Omani patients. The homogenous pattern of ANA was detected in 30/60 (50%) of patients, whereas the frequency of fine-speckled and coarse-speckled was 16/60 (26.7%) and 6/60 (10%), respectively. High titers (≥1:320) of ANA was detected in 56/60 (93.3%) of SLE patients. High titers of anti-Sm were detected in 22/60 (33.3%) of patients. High titers (>100 IU/ml) of anti-dsDNA were detected in 40/60 (66.7%) of patients. In the control group, ANA were detected in 8/60 (13.3%) but at low titers, whereas anti-dsDNA and anti-Sm were not detected in the healthy control group. This study shows that anti-Sm is as important as the anti-dsDNA for confirming the diagnosis of SLE and that anti-Sm occurs at a much higher frequency (83.3%) than that reported in other populations indicating the importance of this specific autoantibody for the diagnosis and possibly prognosis of Omani SLE patients.

Original languageEnglish
Pages (from-to)51-56
Number of pages6
JournalRheumatology International
Volume30
Issue number1
DOIs
Publication statusPublished - Nov 2009

Fingerprint

Systemic Lupus Erythematosus
Autoantibodies
Anti-Idiotypic Antibodies
DNA
Control Groups
Indirect Fluorescent Antibody Technique
Immunoblotting
Stomach
Enzyme-Linked Immunosorbent Assay
Kidney
Liver
Population

Keywords

  • ANA
  • Anti-dsDNA
  • Anti-Sm
  • Autoantibodies
  • Diagnosis
  • Oman
  • Patients
  • SLE

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus. / Al-Jabri, Ali A.; Al-Gahdani, Amal K.; Al-Shuaili, Ibtisam.

In: Rheumatology International, Vol. 30, No. 1, 11.2009, p. 51-56.

Research output: Contribution to journalArticle

Al-Jabri, Ali A. ; Al-Gahdani, Amal K. ; Al-Shuaili, Ibtisam. / High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus. In: Rheumatology International. 2009 ; Vol. 30, No. 1. pp. 51-56.
@article{3ae6bcc116b94dc8a05441334d56f024,
title = "High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus",
abstract = "This study was conducted to investigate the frequency and significance of some antinuclear autoantibodies in Omani patients with systemic lupus erythematosus (SLE). Anti-nuclear antibodies (ANA), anti-double stranded-DNA (anti-dsDNA), and anti-Smith (anti-Sm) autoantibodies were investigated in 60 Omani patients clinically diagnosed with SLE according to the American College of Rheumatology Criteria. The SLE group included 57 females and 3 males with an average age of 26 years. In addition, a group of 60 healthy Omanis (26 females and 34 males; average age 25 years) was used as a control. ANA patterns and autoantibody profile were assayed by indirect immunofluorescence assay using Hep-2 cells and liver/kidney/stomach tissue, respectively. Anti-dsDNA were examined by enzyme-linked immunosorbent assays; anti-Sm antibodies were measured by immunoblotting technique. Out of the 60 SLE patients, 59/60 (98.3{\%}) were seropositive for ANA. Anti-dsDNA and anti-Sm each was detected in 50/60 (83.3{\%}) of the Omani patients. The homogenous pattern of ANA was detected in 30/60 (50{\%}) of patients, whereas the frequency of fine-speckled and coarse-speckled was 16/60 (26.7{\%}) and 6/60 (10{\%}), respectively. High titers (≥1:320) of ANA was detected in 56/60 (93.3{\%}) of SLE patients. High titers of anti-Sm were detected in 22/60 (33.3{\%}) of patients. High titers (>100 IU/ml) of anti-dsDNA were detected in 40/60 (66.7{\%}) of patients. In the control group, ANA were detected in 8/60 (13.3{\%}) but at low titers, whereas anti-dsDNA and anti-Sm were not detected in the healthy control group. This study shows that anti-Sm is as important as the anti-dsDNA for confirming the diagnosis of SLE and that anti-Sm occurs at a much higher frequency (83.3{\%}) than that reported in other populations indicating the importance of this specific autoantibody for the diagnosis and possibly prognosis of Omani SLE patients.",
keywords = "ANA, Anti-dsDNA, Anti-Sm, Autoantibodies, Diagnosis, Oman, Patients, SLE",
author = "Al-Jabri, {Ali A.} and Al-Gahdani, {Amal K.} and Ibtisam Al-Shuaili",
year = "2009",
month = "11",
doi = "10.1007/s00296-009-0909-4",
language = "English",
volume = "30",
pages = "51--56",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus

AU - Al-Jabri, Ali A.

AU - Al-Gahdani, Amal K.

AU - Al-Shuaili, Ibtisam

PY - 2009/11

Y1 - 2009/11

N2 - This study was conducted to investigate the frequency and significance of some antinuclear autoantibodies in Omani patients with systemic lupus erythematosus (SLE). Anti-nuclear antibodies (ANA), anti-double stranded-DNA (anti-dsDNA), and anti-Smith (anti-Sm) autoantibodies were investigated in 60 Omani patients clinically diagnosed with SLE according to the American College of Rheumatology Criteria. The SLE group included 57 females and 3 males with an average age of 26 years. In addition, a group of 60 healthy Omanis (26 females and 34 males; average age 25 years) was used as a control. ANA patterns and autoantibody profile were assayed by indirect immunofluorescence assay using Hep-2 cells and liver/kidney/stomach tissue, respectively. Anti-dsDNA were examined by enzyme-linked immunosorbent assays; anti-Sm antibodies were measured by immunoblotting technique. Out of the 60 SLE patients, 59/60 (98.3%) were seropositive for ANA. Anti-dsDNA and anti-Sm each was detected in 50/60 (83.3%) of the Omani patients. The homogenous pattern of ANA was detected in 30/60 (50%) of patients, whereas the frequency of fine-speckled and coarse-speckled was 16/60 (26.7%) and 6/60 (10%), respectively. High titers (≥1:320) of ANA was detected in 56/60 (93.3%) of SLE patients. High titers of anti-Sm were detected in 22/60 (33.3%) of patients. High titers (>100 IU/ml) of anti-dsDNA were detected in 40/60 (66.7%) of patients. In the control group, ANA were detected in 8/60 (13.3%) but at low titers, whereas anti-dsDNA and anti-Sm were not detected in the healthy control group. This study shows that anti-Sm is as important as the anti-dsDNA for confirming the diagnosis of SLE and that anti-Sm occurs at a much higher frequency (83.3%) than that reported in other populations indicating the importance of this specific autoantibody for the diagnosis and possibly prognosis of Omani SLE patients.

AB - This study was conducted to investigate the frequency and significance of some antinuclear autoantibodies in Omani patients with systemic lupus erythematosus (SLE). Anti-nuclear antibodies (ANA), anti-double stranded-DNA (anti-dsDNA), and anti-Smith (anti-Sm) autoantibodies were investigated in 60 Omani patients clinically diagnosed with SLE according to the American College of Rheumatology Criteria. The SLE group included 57 females and 3 males with an average age of 26 years. In addition, a group of 60 healthy Omanis (26 females and 34 males; average age 25 years) was used as a control. ANA patterns and autoantibody profile were assayed by indirect immunofluorescence assay using Hep-2 cells and liver/kidney/stomach tissue, respectively. Anti-dsDNA were examined by enzyme-linked immunosorbent assays; anti-Sm antibodies were measured by immunoblotting technique. Out of the 60 SLE patients, 59/60 (98.3%) were seropositive for ANA. Anti-dsDNA and anti-Sm each was detected in 50/60 (83.3%) of the Omani patients. The homogenous pattern of ANA was detected in 30/60 (50%) of patients, whereas the frequency of fine-speckled and coarse-speckled was 16/60 (26.7%) and 6/60 (10%), respectively. High titers (≥1:320) of ANA was detected in 56/60 (93.3%) of SLE patients. High titers of anti-Sm were detected in 22/60 (33.3%) of patients. High titers (>100 IU/ml) of anti-dsDNA were detected in 40/60 (66.7%) of patients. In the control group, ANA were detected in 8/60 (13.3%) but at low titers, whereas anti-dsDNA and anti-Sm were not detected in the healthy control group. This study shows that anti-Sm is as important as the anti-dsDNA for confirming the diagnosis of SLE and that anti-Sm occurs at a much higher frequency (83.3%) than that reported in other populations indicating the importance of this specific autoantibody for the diagnosis and possibly prognosis of Omani SLE patients.

KW - ANA

KW - Anti-dsDNA

KW - Anti-Sm

KW - Autoantibodies

KW - Diagnosis

KW - Oman

KW - Patients

KW - SLE

UR - http://www.scopus.com/inward/record.url?scp=71349086955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71349086955&partnerID=8YFLogxK

U2 - 10.1007/s00296-009-0909-4

DO - 10.1007/s00296-009-0909-4

M3 - Article

VL - 30

SP - 51

EP - 56

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

IS - 1

ER -